STAT3 and Familial prostate cancer: Our results showed that Stattic effectively eliminated the ALDHhigh subpopulation in PC3M-1E8 cells and primary cell cultures from different clinical prostate cancer samples, even at a low doses (Fig. 3E), suggesting that this subpopulation of prostate TICs is sensitive to STAT3-mediated inhibition.